HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

DeLauro Whistles For Investigation Of US FDA Response To Whistleblower Report On Abbott Formula Facility

Executive Summary

Appropriations chairwoman Rosa DeLauro wants answers from HHS Office of Inspector General about FDA’s response to whistleblower report of contamination at Abbott Nutrition infant formula facility. Report described pattern of unsatisfactory quality control practices at the plant.

You may also be interested in...



Democrats, Republicans Agree US FDA’s Food Safety Programs Need Help, Disagree On How

Democrats on Oversight and Investigation Subcommittee support increasing funding for FDA’s regulation of food product manufacturing and marketing, but Republicans advise Commissioner Robert Califf the agency should do more with authority it already has and without adding to its budget.

House Appropriation Leaders Propose Emergency Funding For FDA's Infant Formula Programs

Democrats introduce bill two days before Agriculture, Rural Development, FDA and Related Agencies subcommittee will question FDA Commissioner Robert Califf about agency’s oversight of formula industry during a hearing on FY2023 budget.

Before Infant Formula Recall, Abbott ‘Closed-Done’ With Investigation Complaint Referencing Death

FDA report on inspection states Abbott and agency “found evidence" of Cronobacter species bacteria in powdered infant formula production environment and firm also identified bacteria in finished powdered formula products. Once Abbott gets FDA clearance to restart production at facility, it will need as much as two months before formula made there reaches stores.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

RS152516

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel